Mallinckrodt Sees Slight Positive From Tax Reform, Up To $500 Million Benefit
December 22, 2017 at 09:06 AM EST
Mallinckrodt PLC (NYSE: MNK), a generic specialty pharmaceutical company, said Friday in an 8-K filing it expects to see an up to $500 ...